Antihypertensive, antialbuminuric and metabolic effects of manidipine + lisinopril and manidipine, amlodipine, or telmisartan in non-diabetic hypertensive patients with metabolic syndrome

Trial Profile

Antihypertensive, antialbuminuric and metabolic effects of manidipine + lisinopril and manidipine, amlodipine, or telmisartan in non-diabetic hypertensive patients with metabolic syndrome

Completed
Phase of Trial: Phase IV

Latest Information Update: 20 Jun 2011

At a glance

  • Drugs Amlodipine (Primary) ; Lisinopril (Primary) ; Manidipine (Primary) ; Telmisartan (Primary)
  • Indications Essential hypertension; Metabolic syndrome
  • Focus Pharmacodynamics
  • Acronyms MARCADOR
  • Most Recent Events

    • 20 Jun 2011 Results presented at the 21st European Meeting on Hypertension.
    • 05 Nov 2010 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top